Logo image of CPRT

COPART INC (CPRT) Stock Fundamental Analysis

NASDAQ:CPRT - Nasdaq - US2172041061 - Common Stock - Currency: USD

58.29  +0.43 (+0.74%)

Fundamental Rating

7

Taking everything into account, CPRT scores 7 out of 10 in our fundamental rating. CPRT was compared to 84 industry peers in the Commercial Services & Supplies industry. CPRT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CPRT is quite expensive at the moment. It does show a decent growth rate. With these ratings, CPRT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CPRT was profitable.
CPRT had a positive operating cash flow in the past year.
In the past 5 years CPRT has always been profitable.
In the past 5 years CPRT always reported a positive cash flow from operatings.
CPRT Yearly Net Income VS EBIT VS OCF VS FCFCPRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 15.70%, CPRT belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
CPRT has a better Return On Equity (17.64%) than 81.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.44%, CPRT belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPRT is significantly above the industry average of 10.07%.
Industry RankSector Rank
ROA 15.7%
ROE 17.64%
ROIC 15.44%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.78%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
CPRT Yearly ROA, ROE, ROICCPRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CPRT's Profit Margin of 31.92% is amongst the best of the industry. CPRT outperforms 97.56% of its industry peers.
In the last couple of years the Profit Margin of CPRT has grown nicely.
With an excellent Operating Margin value of 36.28%, CPRT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPRT has remained more or less at the same level.
The Gross Margin of CPRT (44.81%) is better than 79.27% of its industry peers.
In the last couple of years the Gross Margin of CPRT has remained more or less at the same level.
Industry RankSector Rank
OM 36.28%
PM (TTM) 31.92%
GM 44.81%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
CPRT Yearly Profit, Operating, Gross MarginsCPRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

CPRT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CPRT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CPRT has more shares outstanding
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CPRT Yearly Shares OutstandingCPRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPRT Yearly Total Debt VS Total AssetsCPRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPRT has an Altman-Z score of 37.09. This indicates that CPRT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CPRT (37.09) is better than 100.00% of its industry peers.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 37.09
ROIC/WACC1.68
WACC9.18%
CPRT Yearly LT Debt VS Equity VS FCFCPRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

CPRT has a Current Ratio of 6.62. This indicates that CPRT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.62, CPRT belongs to the top of the industry, outperforming 93.90% of the companies in the same industry.
A Quick Ratio of 6.55 indicates that CPRT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.55, CPRT belongs to the top of the industry, outperforming 96.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.55
CPRT Yearly Current Assets VS Current LiabilitesCPRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.58% over the past year.
Measured over the past 5 years, CPRT shows a small growth in Earnings Per Share. The EPS has been growing by 4.32% on average per year.
The Revenue has grown by 9.17% in the past year. This is quite good.
CPRT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.72% yearly.
EPS 1Y (TTM)5.58%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%8.82%
Revenue 1Y (TTM)9.17%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%12.39%

3.2 Future

CPRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.08% yearly.
The Revenue is expected to grow by 11.43% on average over the next years. This is quite good.
EPS Next Y14.52%
EPS Next 2Y13.78%
EPS Next 3Y14.17%
EPS Next 5Y12.08%
Revenue Next Year10.38%
Revenue Next 2Y10.01%
Revenue Next 3Y10.95%
Revenue Next 5Y11.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CPRT Yearly Revenue VS EstimatesCPRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CPRT Yearly EPS VS EstimatesCPRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.05, the valuation of CPRT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CPRT.
The average S&P500 Price/Earnings ratio is at 28.47. CPRT is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 32.39, CPRT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as CPRT.
The average S&P500 Price/Forward Earnings ratio is at 92.74. CPRT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 41.05
Fwd PE 32.39
CPRT Price Earnings VS Forward Price EarningsCPRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPRT is valued a bit more expensive than 67.07% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPRT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 56.5
EV/EBITDA 29.16
CPRT Per share dataCPRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CPRT may justify a higher PE ratio.
A more expensive valuation may be justified as CPRT's earnings are expected to grow with 14.17% in the coming years.
PEG (NY)2.83
PEG (5Y)9.5
EPS Next 2Y13.78%
EPS Next 3Y14.17%

0

5. Dividend

5.1 Amount

No dividends for CPRT!.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (2/5/2025, 10:36:05 AM)

58.29

+0.43 (+0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-21 2024-11-21/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners84.98%
Inst Owner Change-0.03%
Ins Owners9.19%
Ins Owner Change0%
Market Cap56.16B
Analysts80
Price Target62.88 (7.87%)
Short Float %1.29%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.95%
Min EPS beat(2)-10.92%
Max EPS beat(2)-0.98%
EPS beat(4)0
Avg EPS beat(4)-4.85%
Min EPS beat(4)-10.92%
Max EPS beat(4)-0.84%
EPS beat(8)4
Avg EPS beat(8)0.06%
EPS beat(12)7
Avg EPS beat(12)-0.75%
EPS beat(16)10
Avg EPS beat(16)2.35%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)2.21%
Revenue beat(4)2
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)2.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.81%
PT rev (1m)0%
PT rev (3m)7.8%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0.32%
EPS NY rev (3m)-3.75%
Revenue NQ rev (1m)0.87%
Revenue NQ rev (3m)1.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.05%
Valuation
Industry RankSector Rank
PE 41.05
Fwd PE 32.39
P/S 12.87
P/FCF 56.5
P/OCF 35.56
P/B 7.11
P/tB 7.68
EV/EBITDA 29.16
EPS(TTM)1.42
EY2.44%
EPS(NY)1.8
Fwd EY3.09%
FCF(TTM)1.03
FCFY1.77%
OCF(TTM)1.64
OCFY2.81%
SpS4.53
BVpS8.2
TBVpS7.59
PEG (NY)2.83
PEG (5Y)9.5
Profitability
Industry RankSector Rank
ROA 15.7%
ROE 17.64%
ROCE 19.41%
ROIC 15.44%
ROICexc 28.26%
ROICexgc 32.54%
OM 36.28%
PM (TTM) 31.92%
GM 44.81%
FCFM 22.78%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.78%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
ROICexc(3y)30.14%
ROICexc(5y)28.88%
ROICexgc(3y)50.08%
ROICexgc(5y)42.59%
ROCE(3y)24.07%
ROCE(5y)25.2%
ROICexcg growth 3Y-0.59%
ROICexcg growth 5Y-0.42%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y0.83%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 290.18%
Cap/Sales 13.42%
Interest Coverage 520.56
Cash Conversion 88.5%
Profit Quality 71.39%
Current Ratio 6.62
Quick Ratio 6.55
Altman-Z 37.09
F-Score5
WACC9.18%
ROIC/WACC1.68
Cap/Depr(3y)278.5%
Cap/Depr(5y)355.84%
Cap/Sales(3y)11.68%
Cap/Sales(5y)15.82%
Profit Quality(3y)72.01%
Profit Quality(5y)63.79%
High Growth Momentum
Growth
EPS 1Y (TTM)5.58%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%8.82%
EPS Next Y14.52%
EPS Next 2Y13.78%
EPS Next 3Y14.17%
EPS Next 5Y12.08%
Revenue 1Y (TTM)9.17%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%12.39%
Revenue Next Year10.38%
Revenue Next 2Y10.01%
Revenue Next 3Y10.95%
Revenue Next 5Y11.43%
EBIT growth 1Y0.8%
EBIT growth 3Y11.42%
EBIT growth 5Y17.02%
EBIT Next Year19.03%
EBIT Next 3Y15.92%
EBIT Next 5Y13.9%
FCF growth 1Y32.5%
FCF growth 3Y22.13%
FCF growth 5Y28.66%
OCF growth 1Y34.35%
OCF growth 3Y14.12%
OCF growth 5Y17.89%